Evidence map›Paper›PMID 41684872›Full record

ArticleSovremennye tekhnologii v meditsine2025

Poly-D,L-Lactide-co-Glycolide and Sodium Enoxaparin Composition - an Advanced Coating for Vascular Stents: Biocompatibility and Efficiency Assessment of Stent-Grafts in an Experiment on Large Animals.

A R Shabaev, N A Kochergin, A Yu Kanonykina, V A Koshelev, A A Arnt, A Yu Kolesnikov, A A Shilov, R S Tarasov, Yu A Kudryavtseva

Abstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

A R ShabaevJunior Researcher, Laboratory of Cellular Technologies, Experimental Medicine Department; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
N A KocherginMD, PhD, Head of the Laboratory of Tissue Engineering and Intravascular Imaging; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
A Yu KanonykinaJunior Researcher, Laboratory of Molecular, Translational, and Digital Medicine, Experimental Medicine Department; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
V A KoshelevJunior Researcher, Laboratory of Molecular, Translational, and Digital Medicine, Experimental Medicine Department; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
A A ArntJunior Researcher, Laboratory of Tissue Engineering and Intravascular Imaging; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
A Yu KolesnikovJunior Researcher, Laboratory of Tissue Engineering and Intravascular Imaging; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
A A ShilovMD, DSc, Head of the Department of X-ray Surgical Diagnostic and Therapeutic Methods; Kuzbass Clinical Cardiology Dispensary named after Academician L.S. Barbarash, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
R S TarasovMD, DSc, Head of the Laboratory of X-ray Endovascular and Reconstructive Cardiovascular Surgery; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.
Yu A KudryavtsevaDSc, Leading Researcher, Experimental Medicine Department; Research Institute for Complex Issues of Cardiovascular Diseases, 6 Academician Barbarash Blvd., Kemerovo, 650002, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: A biodegradable coating based on a copolymer of poly-D,L-lactide-co-glycolide (the polylactide-glycolide ratio - 50:50) and low-molecular sodium enoxaparin was applied on 8-mm-long metallic coronary Calipso stents by electrospinning. The sheep carotid artery was implanted with the coated stents (stent-grafts) and uncoated stents. The dynamic patency was assessed by color duplex ultrasound. Three months later, the artery-stent fragments were explanted, fixed with buffered formalin with post-fixation with osmium tetroxide, dehydrated in ethanol and acetone followed by impregnating with epoxy resin. After polymerization, the samples were ground and polished to the required depth. To enhance the contrast after polishing, the samples were treated with Reynolds lead citrate. The samples were visualized by scanning electron microscopy in the backscattered electron mode. Results: During the three-month experiment, no cases of thrombosis or stenosis of stents and stent-grafts were revealed. A uniform dense neointima up to 165 μm thick formed on the internal surface of the stent-grafts, it was twice as thick as the intima of the intact carotid artery adjacent to the stent-graft. A loose neointima formed on the inner part of the stents without a polymer membrane, reaching 380 μm in some places. All samples demonstrated a classic picture of the formation of a dense fibrous capsule, which separated the metal stent struts from the blood flow and structural elements of the artery, however, the morphology and cellular composition in the samples varied significantly. The struts of the stents without a membrane were surrounded by numerous inflammatory cells. The environment of the stent grafts was represented mainly by smooth muscle cells, fibrocytes, fragments of the elastic membrane located in the intercellular matrix; there were no inflammatory cells. The polymer coating of the stent-grafts completely degraded forming no scar tissue. Conclusion: The developed polymer coating based on a copolymer of poly-D,L-lactide-co-glycolide (the polylactide-glycolide ratio - 50:50) and the low-molecular sodium enoxaparin for a vascular stent appeared to be effective. When implanted in sheep carotid arteries, the stent-grafts cause no development of thrombosis and stenosis, successfully integrating with the animal artery. In 3 months, complete resorption of the polymer coating occurred with no signs of a chronic inflammatory reaction.

Indexed as

Blood Vessel ProsthesisCoated Materials, BiocompatibleDrug-Eluting StentsEnoxaparinLactic AcidPolyglycolic AcidStentsAnimalsCarotid ArteriesMaterials TestingPolylactic Acid-Polyglycolic Acid CopolymerSheepCoated Materials, BiocompatibleEnoxaparinLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymerarterial perforationbiocompatibilitybiodegradable polymersstent-graftvascular stents

Identifiers

PMID41684872
PMCPMC12892849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.